US9186403013 - Common Stock
VACCINEX INC
NASDAQ:VCNX (9/6/2024, 8:00:02 PM)
After market: 5.59 -0.04 (-0.71%)5.63
+0.21 (+3.87%)
Vaccinex, Inc. operates as a clinical-stage biotechnology company. The company is headquartered in Rochester, New York and currently employs 37 full-time employees. The company went IPO on 2018-08-09. The firm is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including neurodegenerative diseases, cancer, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical development for the treatment of Alzheimer’s disease, head and neck, pancreatic and breast cancer. Its lead platform technologies include SEMA4D antibody platform and ActivMAb antibody discovery platform. SEMA4D antibody platform is the application of its knowledge of SEMA4D biology to develop pepinemab for the treatment of various diseases and conditions, including cancer. ActivMAb antibody discovery platform is a human antibody discovery platform based on a method for expressing multipass membrane proteins, as well as large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface of mammalian pox viruses.
VACCINEX INC
1895 Mount Hope Ave
Rochester NEW YORK 14620
P: 15852712700
CEO: Maurice Zauderer
Employees: 37
Website: https://www.vaccinex.com/
Vaccinex just reported results for the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Vaccinex (NASDAQ:VCNX) just reported results for the second quarter of 2024.Vac...
Company reviews goals and significance of the study and outlines development strategy in Mild Cognitive Impairment due to Alzheimer’s disease
Company reviews goals and significance of the clinical trial and outlines development and partnering strategy ...
It's time to start off the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday morning!
Here you can normally see the latest stock twits on VCNX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: